A phase II trial modifying metabolic syndrome and cardiovascular risk for patients with prostate cancer on ADT using a risk factor modification program and continuous Fitbit monitoring (ProTrio) Meeting Abstract
| Authors: | Hahn, A. W.; Slack Tidwell, R.; Thoman, W.; Abdulla, A.; Koutroumpakis, E.; Aparicio, A.; Subudhi, S. K.; Siddiqui, B. A.; PilieĢ, P. G.; Zurita, A. J.; Corn, P. G.; Laccetti, A. L.; Jana, B. R. P.; Basen-Engquist, K.; Logothetis, C. |
| Abstract Title: | A phase II trial modifying metabolic syndrome and cardiovascular risk for patients with prostate cancer on ADT using a risk factor modification program and continuous Fitbit monitoring (ProTrio) |
| Meeting Title: | 2023 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2023 Feb 16-18 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-02-20 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.6_suppl.TPS273 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: TPS273 -- Source: Cinahl |
